Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis
Open Access
- 28 February 2009
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 60 (2), 225-230
- https://doi.org/10.1016/j.jaad.2008.09.046
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Osteopontin Promoter Polymorphism Is Associated With Increased Carotid Intima-Media ThicknessJournal of the American Society of Echocardiography, 2008
- Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammationBritish Journal of Dermatology, 2008
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- Misbehaving macrophages in the pathogenesis of psoriasisJCI Insight, 2006
- Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammationJCI Insight, 2006
- Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammationJCI Insight, 2006
- Cytokine Polymorphisms Associated With Carotid Intima-Media Thickness in Stroke PatientsStroke, 2006
- High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.JCI Insight, 1994
- Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta.JCI Insight, 1993